RxDoctor Payments Data

Abba Zubair, MD

Clinical Pathology/Laboratory Medicine · Jacksonville, FLNPI 1124018049

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Gilead at 38.9% of the total. That places this record below the midpoint for clinical pathology/laboratory medicine clinicians in FL, where the typical reported total is $269.

$152in general payments, 2019–2025

Across 3 payments — averaging $50.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$59
  • Daiichi Sankyo Company LTD$46
  • Cerus Corporation$46
$1,022,483in research payments, 2019–2025

Across 27 payments — averaging $37,870 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Daiichi Sankyo Company LTD$750K
  • Cerus Corporation$272K

What the payments were for

  • Food & beverage$152100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$152 in reported general payments places this provider in the 30th percentile of 43 clinical pathology/laboratory medicine providers in Florida.

See all clinical pathology/laboratory medicine providers in Florida

Medicare billing

Part B allowed, 2024
$3,820
Medicare patients
40
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →